2015 American Transplant Congress
mTOR Inhibitors Reduce the Endothelial Transmigration of Leukocytes After Ischemia
ObjectivemTOR inhibitors Everolimus and Sirolimus are currently used as maintenance immunosuppressive agents to prevent rejection of solid transplanted organs. Episodes of transplant rejection and graft…2015 American Transplant Congress
Local Expansion in DCD Kidney Transplant Activity Improves Waiting List Outcomes and Addresses Inequities of Access to Transplantation
1Cambridge University, Cambridge, United Kingdom; 2NHSBT, Bristol, United Kingdom.
Introduction: Following expansion in our circulatory death (DCD) transplant program, our center now performs twice as many DCD as brain-death (DBD) kidney transplants. Here, we…2015 American Transplant Congress
Unknown Urological Pathologies in Renal Allografts from Deceased Donors. Should Image Evaluation Be Routinely Performed?
Division of Urology, Renal Transplantation Unit, University of Sao Paulo, Sao Paulo, Brazil.
Purpose: In an effort to increase the overall donor pool, the use of extended-criteria kidneys has been routine in the majority of transplant centers. It…2015 American Transplant Congress
Belatacept in a Community Hospital Adult Kidney Transplant Program
Iowa Methodist Medical Center, Des Moines, IA.
PURPOSE:This is a retrospective look (08/2011-11/2014) on data collected from patients transplanted at Iowa Methodist Transplant Center.METHODS:All patients were EBV positive. They were induced with…2015 American Transplant Congress
Epidemiology of Early Post Liver Transplant (LT) Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen?
Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Background: The most common pathogens seen in early post LT intraabdominal and bloodstream infection are enterococci, staphylococci and aerobic gram negative bacilli and perioperative prophylaxis…2015 American Transplant Congress
Utilizing CDC High Risk Donors to Improve Outcomes in Liver Transplantation
General Surgery, Division of Transplant Surgery, Rush University Medical Center, Chicago, IL.
Introduction: An under-utilized demographic in liver transplantation is the CDC high-risk donor (HRD). These individuals, considered at higher risk of blood-borne diseases, contribute approximately 9%…2015 American Transplant Congress
Use of MELD Exception Points in Patients With Hepatic Neuroendocrine Tumor Metastases: Variable Use and Proposed Criterion for Approval
Purpose: Most patients with metastatic neuroendocrine tumors (NETs) have preserved hepatic synthetic function, and their providers may seek increased waitlist priority via MELD exception points.…2015 American Transplant Congress
Early Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation Has No Negative Impact on Patients outcome'
Liver transplantation (LT) is the only therapeutic option for primary sclerosing cholangitis (PSC), however, recurrence of PSC (rPSC) post-LT occurs at rates ranging from 9-47%.…2015 American Transplant Congress
Hand Assisted Retroperitoneoscopic Donor Nephrectomy in Challenging Cases; Right Sided Donor Nephrectomy With Multiple Renal Arteries
Hand-assisted retroperitoneoscopic (HARP) nephrectomy is a potentially safer approach for the donor where the peritoneum stays intact and tactile sensation remains. The experience with HARP…2015 American Transplant Congress
Expanding the Living Donor Pool: Results of ABO Incompatible Living Related Kidney Transplantation
Background: Organ shortage has led to an increase in living related kidney transplantation. Here we report on our program of expanding the living donor pool…
American Transplant Congress abstracts